Qiagen N.V.QGEN

NYSEHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$44.56
Market cap
$9.7B
P/E
22.7x
Revenue (FY)
$2.1B
Net income
$424.9M
Dividend yield
0.79%
1-year total return
2.3%
Net margin
20.3%
Revenue growth
5.7%
Debt / equity
0.44x

What Qiagen N.V. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$1.9B$2.3B$2.1B$2.0B$2.0B$2.1B
Net income$359.2M$512.6M$423.2M$341.3M$83.6M$424.9M
Free cash flow$325.0M$449.1M$586.0M$309.7M$506.4M$453.3M

More on QGEN.

Figures from Qiagen N.V.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.